Tag: GPN Vaccines
-
GPN Vaccines Inc Completes Acquisition of BacVax Inc.
New York, USA – 24th October 2025 GPN Vaccines Inc (“GPN”) is pleased to announce it has successfully completed the acquisition of BacVax Inc. (“BacVax”), a biotechnology company based in Phoenix, Arizona, that is developing vaccines targeting bacterial infections. The acquisition further increases GPN’s footprint in the United States and builds the company’s pipeline through…
